HIGHLIGHTS
- who: Kiyomi Kuba from the DepartmentMedical University have published the paper: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab, in the Journal: Scientific Reports Scientific Reports
- what: The aim of this study was to investigate the correlation between clinicopathological features including original TIL status and progression-free survival (PFS) rate and overall survival (OS) rate in HNSCC patients treated with nivolumab.
SUMMARY
The authors created a combined PD-L1 and intratumoral or stromal C D8+TIL classification, classifying patients with + both . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.